Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PluriCells
- Development stage
- Preclinical
- Lead developer
- Stem Cell Innovations
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
PluriCells is a proprietary human pluripotent stem cell platform developed by Stem Cell Innovations. These cells are isolated from fetal tissue and possess the unique ability to differentiate into all cell types of the human body, including hepatocytes. Designed as an alternative to embryonic stem cells, PluriCells can be cultured efficiently and reproducibly without the use of feeder layers. The technology is intended for applications in drug discovery, toxicology testing, and regenerative medicine, most notably as the biological component of a liver assist device designed to support patients with liver failure awaiting transplantation.
- Brand names
- PluriCells
Beyond the preview
Go deeper on PluriCells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PluriCells.